Ibrar A - Search Results

1

Biosynthesis of Zr-doped WO₃ nanoparticles: Evaluation of antibacterial, antioxidant, and enzymatic activities.

Tahir S, Iqbal M, Shad S, Nisa S, Ibrar A, Nadeem A, Attia SM, Thebo KH, Ullah K. Tahir S, et al. Among authors: ibrar a. Microb Pathog. 2025 Jan;198:107192. doi: 10.1016/j.micpath.2024.107192. Epub 2024 Nov 30. Microb Pathog. 2025. PMID: 39622481

2

Methicillin-Resistant Staphylococcus aureus among Students: Nasal Carriage Rate, Contributing Factors, and Antimicrobial Susceptibility.

Taqveem A, Rasool MH, Aslam B, Mujahid F, Ibrar A, Ejaz H, Abdalla AE, Alruwaili Y, Alruwaili M, Abosalif K, Nawaz Z, Khurshid M. Taqveem A, et al. Among authors: ibrar a. Medicina (Kaunas). 2024 Sep 27;60(10):1590. doi: 10.3390/medicina60101590. Medicina (Kaunas). 2024. PMID: 39459377 Free PMC article.

3

Exploring the Therapeutic Potential of Coumarin-thiazolotriazole Pharmacophores for SARS-CoV-2 Spike Protein through In-vitro and In-silico Evaluation.

Ullah S, Ullah A, Waqas M, Halim SA, Khan I, Ur Rehman S, Abdellattif MH, Soomro S, Ibrar A, Kashtoh H, Khan A, Al-Harrasi A. Ullah S, et al. Among authors: ibrar a. Curr Med Chem. 2024 Sep 23. doi: 10.2174/0109298673323284240911052131. Online ahead of print. Curr Med Chem. 2024. PMID: 39318001

4

Design and discovery of anthranilamide derivatives as a potential treatment for neurodegenerative disorders via targeting cholinesterases and monoamine oxidases.

Zaib S, Khan I, Ali HS, Younas MT, Ibrar A, Al-Odayni AB, Al-Kahtani AA. Zaib S, et al. Among authors: ibrar a. Int J Biol Macromol. 2024 Jun;272(Pt 1):132748. doi: 10.1016/j.ijbiomac.2024.132748. Epub 2024 May 29. Int J Biol Macromol. 2024. PMID: 38821306

5

Urease inhibitory potential of pyridine-containing triazolothiadiazole and triazolothiadiazine scaffolds for the treatment of ulceration and kidney stone: in vitro screening, kinetics mechanism, and in silico computational analysis.

Ullah S, Halim SA, Ibrar A, Khan I, Ataya FS, Fouad D, Batiha GE, Khan A, Al-Harrasi A. Ullah S, et al. Among authors: ibrar a. J Biomol Struct Dyn. 2023 Dec 28:1-10. doi: 10.1080/07391102.2023.2291542. Online ahead of print. J Biomol Struct Dyn. 2023. PMID: 38153364

6

Triazolothiadiazoles and Triazolothiadiazines as New and Potent Urease Inhibitors: Insights from In Vitro Assay, Kinetics Data, and In Silico Assessment.

Uddin J, Ullah S, Halim SA, Waqas M, Ibrar A, Khan I, Bin Muhsinah A, Khan A, Al-Harrasi A. Uddin J, et al. Among authors: ibrar a. ACS Omega. 2023 Aug 23;8(35):31890-31898. doi: 10.1021/acsomega.3c03546. eCollection 2023 Sep 5. ACS Omega. 2023. PMID: 37692208 Free PMC article.

7

Triazolothiadiazoles and triazolothiadiazines as potent α-glucosidase inhibitors: Mechanistic insights from kinetics studies, molecular docking and dynamics simulations.

Ullah S, Waqas M, Halim SA, Khan I, Khalid A, Abdalla AN, Makeen HA, Ibrar A, Khan A, Al-Harrasi A. Ullah S, et al. Among authors: ibrar a. Int J Biol Macromol. 2023 Oct 1;250:126227. doi: 10.1016/j.ijbiomac.2023.126227. Epub 2023 Aug 8. Int J Biol Macromol. 2023. PMID: 37558024

8

Ultrathin Graphene Oxide-Based Nanocomposite Membranes for Water Purification.

Soomro F, Memon FH, Khan MA, Iqbal M, Ibrar A, Memon AA, Lim JH, Choi KH, Thebo KH. Soomro F, et al. Among authors: ibrar a. Membranes (Basel). 2023 Jan 4;13(1):64. doi: 10.3390/membranes13010064. Membranes (Basel). 2023. PMID: 36676871 Free PMC article.

9

Coronary Artery Stent Dislodgement and Loss in the Bloodstream: A Case Report and Management Options.

Khashan A, Talib S, Hamouda M, Kovacs J, Ibrar A, Saini G, Haq ZU, Anantharamakrishnan B, Alam M. Khashan A, et al. Among authors: ibrar a. Am J Case Rep. 2022 Sep 17;23:e937598. doi: 10.12659/AJCR.937598. Am J Case Rep. 2022. PMID: 36114659 Free PMC article.

10

Inhibitory Efficacy of Thiosemicarbazones for Carbonic Anhydrase II (Bovine and Human) as a Target of Calcification and Tumorigenicity.

Khan M, Halim SA, Shafiq Z, Islam M, Shehzad MT, Ibrar A, Khan FA, Marraiki N, Uddin J, Khan A, Al-Harrasi A. Khan M, et al. Among authors: ibrar a. Curr Pharm Des. 2022;28(36):3010-3022. doi: 10.2174/1381612828666220729105849. Curr Pharm Des. 2022. PMID: 35909284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters